drugset / Trial / NCT03669562

The Safety and Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers

NCT03669562

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Conducted in Chinese healthy adult volunteers,the study aims to observe the safety, tolerability and pharmacokinetic of single-dose administration of different doses of Alprostadil Liposome for Injection as well as to confirm the safety dose range.

Timeline

Start
2018-08-07
Primary completion
2018-10-15
Completion
2018-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprostadil Unknown Intravenous